CQC registers UK clinic to prescribe medical cannabis
The CQC decision marks the first time the agency has accepted a clinic to prescribe patients with medical cannabis in the UK.
List view / Grid view
The CQC decision marks the first time the agency has accepted a clinic to prescribe patients with medical cannabis in the UK.
4 October 2019 | By Mettler-Toledo GmbH
This webinar provides an overview of the important UV/Vis spectroscopy-relevant changes in both USP and Ph. Eur. taking a closer look at their impact and the solutions available to ensure compliance.
The FDA recommends drug manufacturers to use LC-HRMS to test for NDMA in ranitidine products, as high temperatures generate the impurity.
The FDA and DEA have, for the first time, sent joint warning letters to four networks which were illegally selling opioid products.
2 October 2019 | By SUEZ – Ozonia® Ozone Systems
This webinar guides you through efficiency gains with TOC for cleaning validation. We call it a ‘beginner’s guide’, but the session will benefit long-time TOC users as well as those new to using TOC for cleaning validation.
CPhI Worldwide now comprises six individual pharma events and more than 20 dedicated zones.
In an effort to prevent harm through contamination, the U.S. Pharmacopeial Convention has been working on a series of proposed changes to USP Chapter 797, Pharmaceutical Compounding– Sterile Preparations.
A survey of pharmacists has discovered that UK pharmacies experienced shortages across all 36 medicine categories in the last six months.
The European Medicines Agency has issued advice to pharmaceutical companies on how to avoid the presence of nitrosamines in medicines.
This article explores the potential of readily available technology to address current traceability challenges as well as more wide-ranging issues in the pharmaceutical industry.
NICE has announced that it will not be recommending erenumab, an injectable migraine treatment, due to issues with cost and its long-term effectiveness.
The probable carcinogen N-nitrosodimethylamine was detected in Sandoz’s ranitidine capsules, prompting the voluntary move.
The Jynneos live, non-replicating vaccination for smallpox and monkeypox has been approved by the FDA for high-risk patients.
The FDA grants Orphan Drug Designation to treatments for rare diseases in R&D; here are the 10 most recent for oncologic conditions.
FDA announces the voluntary recall for the losartan medications has been extended to include more lots, after impurities were found in the drugs.